Deutsche Märkte geschlossen

Awakn Life Sciences Corp. (954.F)

Frankfurt - Frankfurt Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
0,0445-0,0070 (-13,59%)
Börsenschluss: 08:10AM CEST

Insider-Transaktionen

Währung in EUR
Insider-Käufe (letzte 6 Monate)AktienTrans
Käufe00
VerkaufN/A0
Gekaufte Nettoaktien (verkauft)00
Insideraktien mit Beteiligung (gesamt)3,34MN/A
% Gekaufte Nettoaktien (verkauft)N/AN/A
Institutionelle Käufe (netto) der letzten QuartaleAktien
Gekaufte Nettoaktien (verkauft)N/A
% Schwankung in institutioneller AktienbeteiligungN/A

Gemeldete Insider-Transaktionen – Letzte zwei Jahre

InsiderTransaktionTypWertDatumAktien

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition under a prospectus exemption at price 0.42 per share.Indirekt10.40015. Sept. 202225.000

Nutt (David John)
Senior Officer of Issuer

Acquisition or disposition under a prospectus exemption at price 0.42 per share.Indirekt25.08014. Sept. 202260.000

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition in the public market at price 0.49 per share.Indirekt97422. Juni 20222.000

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition in the public market at price 0.49 per share.Indirekt4.14821. Juni 20228.500

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition in the public market at price 0.42 per share.Indirekt4.22017. Juni 202210.000

Scorsis (George)
Director of Issuer

Acquisition or disposition in the public market at price 0.98 per share.Direkt58924. Mai 2022600

Scorsis (George)
Director of Issuer

Acquisition or disposition in the public market at price 0.97 per share.Direkt48724. Mai 2022500

Scorsis (George)
Director of Issuer

Acquisition or disposition in the public market at price 1.22 per share.Direkt48920. Apr. 2022400

Scorsis (George)
Director of Issuer

Acquisition or disposition in the public market at price 1.21 per share.Direkt48518. Apr. 2022400

Scorsis (George)
Director of Issuer

Acquisition or disposition in the public market at price 1.21 per share.Direkt60618. Apr. 2022500

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition under a prospectus exemption at price 1.27 per share.Direkt19.82721. März 202215.600

Nutt (David John)
Senior Officer of Issuer

Acquisition or disposition under a prospectus exemption at price 1.27 per share.Indirekt38.44721. März 202230.250

Orbimed Capital, L.L.C.
10% Security Holder of Issuer

Acquisition or disposition under a prospectus exemption at price 1.27 per share.Indirekt397.18721. März 2022312.500

Papastergiou (John)
Director of Issuer

Acquisition or disposition under a prospectus exemption at price 1.27 per share.Indirekt39.71821. März 202231.250

Scorsis (George)
Director of Issuer

Acquisition or disposition under a prospectus exemption at price 1.27 per share.Direkt19.82721. März 202215.600

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition in the public market at price 1.69 per share.Indirekt1.69024. Jan. 20221.000

Scorsis (George)
Director of Issuer

Acquisition or disposition in the public market at price 1.88 per share.Direkt3.98421. Jan. 20222.125

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition in the public market at price 2.05 per share.Indirekt2.05419. Jan. 20221.000

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition in the public market at price 2.01 per share.Indirekt4.22918. Jan. 20222.100

Held, Jonathan James
Senior Officer of Issuer

Acquisition or disposition in the public market at price 2.12 per share.Indirekt12.70217. Jan. 20226.000

Carter (Paul Rutherford)
Director of Issuer

Direkt14. Dez. 20210